Drugs / AUT00206
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03164876 | Apr 2017 → Apr 2019 | schizophrenia | Autifony Therapeutics Limited | Completed | No outcome recorded |
| Phase 1 | NCT02935725 | Oct 2016 → Nov 2017 | schizophrenia | Autifony Therapeutics Limited | Completed | No outcome recorded |
| Phase 1 | NCT02589262 | Sep 2015 → Jul 2016 | schizophrenia | Autifony Therapeutics Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AUT00206 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02589262 ↗ |
| Modality | Small molecule | — CHEMBL5314948 ↗ |
| Route | Oral | “by mouth” NCT02589262 ↗ |